Tofacitinib Shows Promise in Psoriatic Arthritis

Tofacitinib is better than placebo for psoriatic arthritis that has responded poorly to treatment with conventional disease-modifying antirheumatic drugs and tumor necrosis factor inhibitors.
Medscape Medical News

http://ift.tt/2zzNwWG